1. Home
  2. ADAP vs WPRT Comparison

ADAP vs WPRT Comparison

Compare ADAP & WPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • WPRT
  • Stock Information
  • Founded
  • ADAP 2008
  • WPRT 1995
  • Country
  • ADAP United Kingdom
  • WPRT Canada
  • Employees
  • ADAP N/A
  • WPRT N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • WPRT Industrial Machinery/Components
  • Sector
  • ADAP Health Care
  • WPRT Industrials
  • Exchange
  • ADAP Nasdaq
  • WPRT Nasdaq
  • Market Cap
  • ADAP 75.5M
  • WPRT 69.7M
  • IPO Year
  • ADAP 2015
  • WPRT 1995
  • Fundamental
  • Price
  • ADAP $0.08
  • WPRT $3.66
  • Analyst Decision
  • ADAP Hold
  • WPRT Buy
  • Analyst Count
  • ADAP 6
  • WPRT 3
  • Target Price
  • ADAP $1.02
  • WPRT $6.33
  • AVG Volume (30 Days)
  • ADAP 18.4M
  • WPRT 29.3K
  • Earning Date
  • ADAP 08-11-2025
  • WPRT 08-11-2025
  • Dividend Yield
  • ADAP N/A
  • WPRT N/A
  • EPS Growth
  • ADAP N/A
  • WPRT N/A
  • EPS
  • ADAP N/A
  • WPRT N/A
  • Revenue
  • ADAP $179,639,000.00
  • WPRT $295,680,000.00
  • Revenue This Year
  • ADAP N/A
  • WPRT N/A
  • Revenue Next Year
  • ADAP $38.72
  • WPRT N/A
  • P/E Ratio
  • ADAP N/A
  • WPRT N/A
  • Revenue Growth
  • ADAP 878.53
  • WPRT N/A
  • 52 Week Low
  • ADAP $0.08
  • WPRT $2.50
  • 52 Week High
  • ADAP $1.36
  • WPRT $6.20
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 25.83
  • WPRT 53.05
  • Support Level
  • ADAP $0.08
  • WPRT $3.06
  • Resistance Level
  • ADAP $0.36
  • WPRT $4.10
  • Average True Range (ATR)
  • ADAP 0.02
  • WPRT 0.21
  • MACD
  • ADAP -0.02
  • WPRT -0.04
  • Stochastic Oscillator
  • ADAP 1.38
  • WPRT 30.00

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

Share on Social Networks: